1. Home
  2. CMPX vs ATLO Comparison

CMPX vs ATLO Comparison

Compare CMPX & ATLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CMPX
  • ATLO
  • Stock Information
  • Founded
  • CMPX 2014
  • ATLO 1903
  • Country
  • CMPX United States
  • ATLO United States
  • Employees
  • CMPX N/A
  • ATLO N/A
  • Industry
  • CMPX Biotechnology: Pharmaceutical Preparations
  • ATLO Major Banks
  • Sector
  • CMPX Health Care
  • ATLO Finance
  • Exchange
  • CMPX Nasdaq
  • ATLO Nasdaq
  • Market Cap
  • CMPX 214.6M
  • ATLO 144.8M
  • IPO Year
  • CMPX N/A
  • ATLO N/A
  • Fundamental
  • Price
  • CMPX $2.00
  • ATLO $16.98
  • Analyst Decision
  • CMPX Strong Buy
  • ATLO
  • Analyst Count
  • CMPX 4
  • ATLO 0
  • Target Price
  • CMPX $13.75
  • ATLO N/A
  • AVG Volume (30 Days)
  • CMPX 1.8M
  • ATLO 29.1K
  • Earning Date
  • CMPX 11-12-2024
  • ATLO 01-21-2025
  • Dividend Yield
  • CMPX N/A
  • ATLO 6.00%
  • EPS Growth
  • CMPX N/A
  • ATLO N/A
  • EPS
  • CMPX N/A
  • ATLO 0.98
  • Revenue
  • CMPX $850,000.00
  • ATLO $51,071,000.00
  • Revenue This Year
  • CMPX N/A
  • ATLO N/A
  • Revenue Next Year
  • CMPX $613.39
  • ATLO N/A
  • P/E Ratio
  • CMPX N/A
  • ATLO $17.06
  • Revenue Growth
  • CMPX N/A
  • ATLO N/A
  • 52 Week Low
  • CMPX $0.77
  • ATLO $15.69
  • 52 Week High
  • CMPX $2.68
  • ATLO $22.41
  • Technical
  • Relative Strength Index (RSI)
  • CMPX 65.48
  • ATLO 55.06
  • Support Level
  • CMPX $1.43
  • ATLO $16.04
  • Resistance Level
  • CMPX $2.68
  • ATLO $16.62
  • Average True Range (ATR)
  • CMPX 0.24
  • ATLO 0.40
  • MACD
  • CMPX 0.06
  • ATLO 0.09
  • Stochastic Oscillator
  • CMPX 46.87
  • ATLO 90.44

About CMPX Compass Therapeutics Inc.

Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to broadly drug the immune system and identify optimal combinations empirically. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of three product candidates, CTX-009, CTX-471, and CTX-8371.

About ATLO Ames National Corporation

Ames National Corporation is a United States-based bank holding company. Through its subsidiaries, it provides checking, savings and time deposits, cash management services, merchant credit card processing, safe deposit boxes, wire transfers, direct deposit of payroll and social security checks, and automated/video teller machine access. Its loan portfolio comprises commercial, residential & agricultural real estate loans; agricultural & business operating loans & lines of credit; equipment loans; vehicle loans; personal loans; and mortgage loans. Its operations are conducted in central, north central, and south-central Iowa.

Share on Social Networks: